Optimize Zn:fCu ratio

From ApoE4.Info Wiki
Revision as of 00:16, 20 June 2016 by Circular (talk | contribs)
Jump to navigation Jump to search

The nineteenth intervention to reverse mild Alzheimer's in the Bredesen Protocol is:

Goal: Optimize Zn:fCu ratio to 1:1
Approach: Depends on values obtained
References: Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease
Metabolic profiling distinguishes three subtypes of Alzheimer's disease
Inhalational Alzheimer's disease: an unrecognized - and treatable - epidemic

Zinc is involved in multiple Alzheimer's-related metabolic processes, such as insulin resistance, chronic inflammation, ADAM10 proteolytic activity, and hormonal signaling.

One of the symptoms, signs, and laboratory values suggestive of type 3 Alzheimer's disease is Low serum zinc (<75mcg/dl) or RBC zinc, or high copper:zinc ratio (>1.3)


The next intervention in the Bredesen Protocol is Ensure nocturnal oxygenation.